These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26582469)

  • 1. Long-term follow-up of a patient with 5q31.3 microdeletion syndrome and the smallest de novo 5q31.2q31.3 deletion involving PURA.
    Bonaglia MC; Zanotta N; Giorda R; D'Angelo G; Zucca C
    Mol Cytogenet; 2015; 8():89. PubMed ID: 26582469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 25 Mainland Chinese cohort of patients with PURA-related neurodevelopmental disorders: clinical delineation and genotype-phenotype correlations.
    Dai W; Sun Y; Fan Y; Gao Y; Zhan Y; Wang L; Xiao B; Qiu W; Gu X; Sun K; Yu Y; Xu N
    Eur J Hum Genet; 2023 Jan; 31(1):112-121. PubMed ID: 36376392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the clinical phenotype and genetic spectrum of PURA-related neurodevelopmental disorders.
    Choi SA; Lee HS; Park TJ; Park S; Ko YJ; Kim SY; Lim BC; Kim KJ; Chae JH
    Brain Dev; 2021 Oct; 43(9):912-918. PubMed ID: 34116881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5q31.3 Microdeletion syndrome: clinical and molecular characterization of two further cases.
    Brown N; Burgess T; Forbes R; McGillivray G; Kornberg A; Mandelstam S; Stark Z
    Am J Med Genet A; 2013 Oct; 161A(10):2604-8. PubMed ID: 23950017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical phenotype and candidate genes for the 5q31.3 microdeletion syndrome.
    Hosoki K; Ohta T; Natsume J; Imai S; Okumura A; Matsui T; Harada N; Bacino CA; Scaglia F; Jones JY; Niikawa N; Saitoh S
    Am J Med Genet A; 2012 Aug; 158A(8):1891-6. PubMed ID: 22711443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infantile spasms related to a 5q31.2-q31.3 microdeletion including
    Shimojima K; Okamoto N; Ohmura K; Nagase H; Yamamoto T
    Hum Genome Var; 2018; 5():18007. PubMed ID: 29619234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo mutations in PURA are associated with hypotonia and developmental delay.
    Tanaka AJ; Bai R; Cho MT; Anyane-Yeboa K; Ahimaz P; Wilson AL; Kendall F; Hay B; Moss T; Nardini M; Bauer M; Retterer K; Juusola J; Chung WK
    Cold Spring Harb Mol Case Stud; 2015 Oct; 1(1):a000356. PubMed ID: 27148565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome.
    Lalani SR; Zhang J; Schaaf CP; Brown CW; Magoulas P; Tsai AC; El-Gharbawy A; Wierenga KJ; Bartholomew D; Fong CT; Barbaro-Dieber T; Kukolich MK; Burrage LC; Austin E; Keller K; Pastore M; Fernandez F; Lotze T; Wilfong A; Purcarin G; Zhu W; Craigen WJ; McGuire M; Jain M; Cooney E; Azamian M; Bainbridge MN; Muzny DM; Boerwinkle E; Person RE; Niu Z; Eng CM; Lupski JR; Gibbs RA; Beaudet AL; Yang Y; Wang MC; Xia F
    Am J Hum Genet; 2014 Nov; 95(5):579-83. PubMed ID: 25439098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability.
    Hunt D; Leventer RJ; Simons C; Taft R; Swoboda KJ; Gawne-Cain M; ; Magee AC; Turnpenny PD; Baralle D
    J Med Genet; 2014 Dec; 51(12):806-13. PubMed ID: 25342064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in manifestations of epilepsy and developmental delay in PURA syndrome and 5q31 microdeletions.
    Kofoed AWS; Kristiansen SS; Miranda MJ; Rubboli G; Johannesen KM
    Clin Genet; 2024 Jun; ():. PubMed ID: 38923490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular and Neuromuscular Junction Manifestations of the PURA-NDD: A Systematic Review of the Reported Symptoms and Potential Treatment Options.
    Mroczek M; Iyadurai S
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient with a novel purine-rich element binding protein A mutation.
    Okamoto N; Nakao H; Niihori T; Aoki Y
    Congenit Anom (Kyoto); 2017 Nov; 57(6):201-204. PubMed ID: 28164378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal PURA syndrome: a case report and literature review.
    Liu Y; Liu R; Xu T; Zhou YX; Zhang SC
    Transl Pediatr; 2021 Jan; 10(1):194-203. PubMed ID: 33633953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5q31 Microdeletions: Definition of a Critical Region and Analysis of LRRTM2, a Candidate Gene for Intellectual Disability.
    Kleffmann W; Zink AM; Lee JA; Senderek J; Mangold E; Moog U; Rappold GA; Wohlleber E; Engels H
    Mol Syndromol; 2012 Aug; 3(2):68-75. PubMed ID: 23326251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PURA syndrome: clinical delineation and genotype-phenotype study in 32 individuals with review of published literature.
    Reijnders MRF; Janowski R; Alvi M; Self JE; van Essen TJ; Vreeburg M; Rouhl RPW; Stevens SJC; Stegmann APA; Schieving J; Pfundt R; van Dijk K; Smeets E; Stumpel CTRM; Bok LA; Cobben JM; Engelen M; Mansour S; Whiteford M; Chandler KE; Douzgou S; Cooper NS; Tan EC; Foo R; Lai AHM; Rankin J; Green A; Lönnqvist T; Isohanni P; Williams S; Ruhoy I; Carvalho KS; Dowling JJ; Lev DL; Sterbova K; Lassuthova P; Neupauerová J; Waugh JL; Keros S; Clayton-Smith J; Smithson SF; Brunner HG; van Hoeckel C; Anderson M; Clowes VE; Siu VM; Ddd Study T; Selber P; Leventer RJ; Nellaker C; Niessing D; Hunt D; Baralle D
    J Med Genet; 2018 Feb; 55(2):104-113. PubMed ID: 29097605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Protein Effects Underpinning Cognitive Developmental Delay of the
    López-Rivera JJ; Rodríguez-Salazar L; Soto-Ospina A; Estrada-Serrato C; Serrano D; Chaparro-Solano HM; Londoño O; Rueda PA; Ardila G; Villegas-Lanau A; Godoy-Corredor M; Cuartas M; Vélez JI; Vidal OM; Isaza-Ruget MA; Arcos-Burgos M
    Brain Sci; 2022 Jun; 12(7):. PubMed ID: 35884678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: Expanding the phenotypic spectrum of PURA syndrome in South America with the first presentation of concurrent vitiligo.
    Mora-Martinez S; Castaño-Giraldo N; Nati-Castillo HA; Barahona Machado L; Mora Arbeláez T; Gordillo-Gonzalez G; Izquierdo-Condoy JS
    Front Pediatr; 2024; 12():1323014. PubMed ID: 38606370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the neurodevelopmental phenotype of PURA syndrome.
    Lee BH; Reijnders MRF; Abubakare O; Tuttle E; Lape B; Minks KQ; Stodgell C; Bennetto L; Kwon J; Fong CT; Gripp KW; Marsh ED; Smith WE; Huq AM; Coury SA; Tan WH; Solis O; Mehta RI; Leventer RJ; Baralle D; Hunt D; Paciorkowski AR
    Am J Med Genet A; 2018 Jan; 176(1):56-67. PubMed ID: 29150892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical region in 2q31.2q32.3 deletion syndrome: Report of two phenotypically distinct patients, one with an additional deletion in Alagille syndrome region.
    Ferreira SI; Matoso E; Venâncio M; Saraiva J; Melo JB; Carreira IM
    Mol Cytogenet; 2012 May; 5(1):25. PubMed ID: 22550961
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.